The 2025 Session of the Indiana General Assembly is underway.
Please check our Advocacy Page for updates on issues we’re following and for upcoming events and programs.
Key Session Dates
- Organization Day – November 19, 2024
- Convene – January 8, 2025
- Bill File Deadlines – House – January 14, 2025, Senate – January 9, 2025
- Deadline for Bills to Switch Houses – February 20, 2025
- Adjournment – April 29, 2025 (or earlier)
- Current Session Deadlines (subject to change)
- Committees of Interest
Bill Track – 2025 Session
Struck-through bills are no longer active
Submit a bill
Bill | Short Title | Sponsors | Committee Status (Assigned) |
SENATE | | | |
SB 3 | Fiduciary duty in health plan administration. | Busch, Charbonneau, Garten | Referred to House Insurance |
SB 33 | Consumer genetic testing providers. | Hunley | Referred to House Public Health |
SB 96 | Pharmacist administration of immunizations. | Becker/Young | Referred to House Public Health |
SB 118 | 340B drug program report. | Charbonneau | Referred to House Public Health |
SB 133 | Restriction on co-pay accumulators. | Ford | |
SB 136 | Disclosures related to prescription drugs. | Bohacek | |
SB 140 | Pharmacy benefits. | Charbonneau | Referred to House Insurance |
SB 145 | Pharmacy matters. | Busch | |
SB 185 | Coverage for Parkinson’s and Alzheimer’s patients. | Dernulc | |
SB 220 | State employee health plan coverage of Alzheimer’s. | Walker | |
SB 237 | Individualized investigational treatment. | Johnson | |
SB 251 | Indiana economic development corporation. | Deery | |
SB 435 | Prohibition on copay accumulator adjustments. | Hunley, Ford, Yoder | |
SB 443 | Business personal property tax. | Freeman, Garten | Referred to House Ways and Means |
SB 465 | Certified technology parks. | Bassler | Referred to House Ways and Means |
SB 480 | Prior authorization. | Johnson | Referred to House Insurance |
SB 503 | Pharmacy benefit administration. | Zay, Charbonneau | |
SB 514 | Chimeric antigen receptor T-cell therapy. | Leising | |
SB 516 | Economic development and small business innovation. | Buchannan | Referred to House Ways and Means |
SB 538 | PFAS chemicals. | Zay | |
HOUSE | | | |
HB 1003 | Health matters. | Barrett, Lehman, ISA | Referred to Senate – reassigned to Health and Provider Services |
HB 1044 | Dissolution of human remains. | Genda/Bartels | Referred to Senate – Commerce and Technology |
HB 1061 | Coverage for cancer screening. | Pryor | |
HB 1062 | Coverage for certain cancer prescriptions. | Pryor | |
HB 1065 | Cancer clinical trial program. | Shackleford | Referred to Senate Health and Provider Services |
HB 1127 | Biofuel tax credits. | Heine | |
HB 1138 | Coverage for obesity treatments. | Shackleford | |
HB 1160 | Student immunizations. | Cash/Carbaugh/McGuire | |
HB 1166 | Appropriation for psilocybin research. | Moed/Teshka | |
HB 1172 | Office of entrepreneurship and innovation. | Teshka/Snow/King | Referred to Senate – Commerce and Technology |
HB 1202 | Medicaid coverage for treatment of obesity. | Shackleford | |
HB 1252 | Limitation on cost sharing. | Smaltz | |
HB 1264 | Nondisclosure agreements in economic development. | Greene | |
HB 1269 | Indiana economic development corporation. | Commons, Greene, Shonkwiler, Haggard | |
HB 1286 | PFAS chemicals. | Cash, McGuire | |
HB 1299 | Funding for breast cancer research. | King |
|
HB 1344 | Indiana vaccination adverse event reporting system. | Borders | |
HB 1366 | PFAS water safety standards. | Dvorak | |
HB 1453 | Pediatric cancer research and treatment grant. | O’Brien, Lauer, Greene | Referred to Senate Health and Provider Services |
HB 1458 | Adoption of research animals. | Hall, Baird, Pierce, Miller | Referred to Senate Public Policy |
HB 1488 | Pediatric cancer research and treatment grant. | Lauer | |
HB 1489 | Indiana-Ireland trade commission. | O’Brien, Baird, Wesco, DeLaney | Referred to Senate – Commerce and Technology |
HB 1521 | Consumer genetic testing providers. | Pierce, Morris, Commons | Referred to Senate Commerce and Technology |
HB 1604 | Out-of-pocket expense credit. | McGuire, King, Morris, Shackleford | Passed out of Senate Insurance Committee 6-1, 3/19/25 |
HB 1606 | Pharmacy benefit managers. | McGuire, Barret, King, Isa | |
HB 1620 | Disclosure of artificial intelligence use in health care. | King | |
HB 1632 | Health care entity mergers. | Smaltz, Barrett, Gore | |
HB 1683 | Certified technology parks. | Lopez, Snow | |
Notes, Links, and Updates
1/13/25 – IN Life Sciences Association provided a Letter of Support for HB 1299 – Breast cancer research funding
1/29/25 – IN Life Sciences Association testified in support of SB 118 – 340B reporting
2/4/25 – IN Life Sciences Association provided note of support for HB 1252 – Limitation on cost sharing.
2/5 – IN Life Sciences Association provided note of support for SB 33 – Consumer genetic testing providers., as written
2/11 – IN Life Sciences Association provided a note of support for HB 1065 – Cancer clinical trial program, as amended.
3/10 – Provided letters of support for breast cancer funding to Senate Health and Appropriations Committee.
3/11 – Provided letters of opposition for HB 1458 – Adoption of research animals.
3/25 – IN Life Sciences Association testified in House Health Committee on SB 118 – 340B reporting.